| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.784 | 0.003 | 0.811 | DNA synthesis inhibitor | 0.694 0.005 DBMET03008 0.811 0.003 DBMET03009 | DBMET03009 | |
| 0.709 | 0.008 | 0.722 | Antibacterial | 0.675 0.011 DBMET03008 0.722 0.007 DBMET03009 | DBMET03009 | |
| 0.663 | 0.004 | 0.667 | Topoisomerase II inhibitor | 0.615 0.004 DBMET03008 0.667 0.004 DBMET03009 | DBMET03009 | |
| 0.48 | 0.003 | 0.49 | DNA gyrase inhibitor | 0.371 0.004 DBMET03008 0.49 0.003 DBMET03009 | DBMET03009 | |
| 0.299 | 0.003 | 0.413 | Topoisomerase II beta inhibitor | 0.171 0.004 DBMET03008 0.413 0.002 DBMET03009 | DBMET03009 | |
| 0.213 | 0.013 | 0.219 | Topoisomerase II alpha inhibitor | 0.153 0.023 DBMET03008 0.219 0.013 DBMET03009 | DBMET03009 | |
| 0.184 | 0.002 | 0.194 | DNA gyrase subunit A inhibitor | 0.158 0.003 DBMET03008 0.194 0.002 DBMET03009 | DBMET03009 | |
| 0.197 | 0.027 | 0.197 | Topoisomerase I inhibitor | 0.143 0.044 DBMET03008 0.197 0.027 DBMET03009 | ||
| 0.242 | 0.085 | 0.244 | DNA damaging | 0.244 0.084 DBMET03009 | DBMET03009 | |
| 0.158 | 0.003 | 0.202 | DNA topoisomerase IV inhibitor | 0.092 0.004 DBMET03008 0.202 0.003 DBMET03009 | DBMET03009 | |
| 0.178 | 0.029 | 0.178 | Antibacterial (Helicobacter pylori) | 0.168 0.034 DBMET03009 | ||
| 0.15 | 0.004 | 0.174 | DNA gyrase subunit B inhibitor | 0.045 0.017 DBMET03008 0.174 0.004 DBMET03009 | DBMET03009 | |
| 0.164 | 0.037 | 0.189 | DNA intercalator | 0.189 0.029 DBMET03008 0.158 0.039 DBMET03009 | DBMET03008 | |
| 0.124 | 0.025 | 0.124 | mTOR complex 1 inhibitor | 0.103 0.055 DBMET03008 0.12 0.029 DBMET03009 | ||
| 0.11 | 0.02 | 0.11 | HIV-1 integrase inhibitor | 0.072 0.046 DBMET03008 0.102 0.024 DBMET03009 | ||
| 0.158 | 0.105 | 0.158 | P-glycoprotein inhibitor | |||
| 0.2 | 0.158 | 0.2 | Nootropic | 0.187 0.176 DBMET03009 | ||
| 0.098 | 0.059 | 0.134 | Pim-1 kinase inhibitor | 0.134 0.034 DBMET03009 | DBMET03009 | |
| 0.119 | 0.101 | 0.119 | Cell wall synthesis inhibitor | 0.115 0.107 DBMET03009 | ||
| 0.138 | 0.125 | 0.138 | Lipocortins synthesis antagonist | |||
| 0.054 | 0.044 | 0.054 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.128 | 0.122 | 0.128 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.104 | 0.1 | 0.152 | Glycogen synthase kinase-3 alpha inhibitor | 0.152 0.065 DBMET03009 | DBMET03009 | |
| 0.043 | 0.047 | 0.076 | 5 Hydroxytryptamine 2 agonist | 0.076 0.016 DBMET03009 | DBMET03009 | |
| 0.032 | 0.046 | 0.092 | 5 Hydroxytryptamine 2C agonist | 0.092 0.009 DBMET03009 | DBMET03009 | |
| 0.15 | 0.167 | 0.17 | Interleukin agonist | 0.17 0.148 DBMET03009 | DBMET03009 | |
| 0.108 | 0.126 | 0.134 | Acetylcholine M1 receptor antagonist | 0.134 0.091 DBMET03008 | DBMET03008 | |
| 0.069 | 0.103 | 0.089 | Urease inhibitor | 0.089 0.08 DBMET03009 | DBMET03009 | |
| 0.145 | 0.191 | 0.167 | 5 Hydroxytryptamine release stimulant | 0.167 0.156 DBMET03009 | DBMET03009 | |
| 0.21 | 0.257 | 0.305 | Calcium channel L-type activator | 0.305 0.153 DBMET03009 | DBMET03009 | |
| 0.036 | 0.094 | 0.067 | 5 Hydroxytryptamine agonist | 0.067 0.049 DBMET03009 | DBMET03009 | |
| 0.028 | 0.122 | 0.058 | 5 Hydroxytryptamine 2A agonist | 0.058 0.049 DBMET03009 | DBMET03009 | |
| 0.031 | 0.126 | 0.069 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.069 0.054 DBMET03008 | DBMET03008 | |
| 0.185 | 0.335 | 0.241 | 5 Hydroxytryptamine release inhibitor | 0.241 0.24 DBMET03009 | DBMET03009 | |
| 0.056 | 0.376 | 0.234 | Polo-like kinase-3 inhibitor | 0.234 0.03 DBMET03008 | DBMET03008 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |